Healthcare Law Today

FEBRUARY 1, 2022

Improves clinical trials by requiring the Food and Drug Administration (FDA) to issue guidance on the use of digital health technologies in clinical trials; decentralized clinical trials; and other innovative designs to support development of new drugs. Senators Murray and Burr expect the legislation to progress this year.

COVID-19 98

COVID-19 FDA Public Health Health Services Administration 98

Health Law Advisor

MARCH 7, 2023

Should the final rules limit the issuance of prescriptions of controlled medications to the FDA-approved indications contained in the FDA-approved labeling for those medications? DEA has specifically requested feedback on whether it should limit telemedicine prescribing to only the drug’s FDA-approved indications. 21 U.S.C. §

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Bill of Health

NOVEMBER 15, 2023

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.

Governance 167

Governance Public Health Telemedicine Medicaid 167

C&M Health Law

JANUARY 25, 2023

For more information, or to better understand how the Act impacts your organization, please contact the professionals listed below, or your regular Crowell & Moring contact. The guidance must address recommendations related to advance digital health technologies (e.g.,

Medicaid 104

Medicaid Medicaid Medicare Medicare 104